company background image
EAPI logo

Euroapi ENXTPA:EAPI Stock Report

Last Price

€2.81

Market Cap

€267.7m

7D

-5.5%

1Y

-49.9%

Updated

22 Dec, 2024

Data

Company Financials +

EAPI Stock Overview

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. More details

EAPI fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Euroapi S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Euroapi
Historical stock prices
Current Share Price€2.81
52 Week High€7.02
52 Week Low€2.26
Beta0.53
1 Month Change-20.22%
3 Month Change-30.38%
1 Year Change-49.91%
3 Year Changen/a
5 Year Changen/a
Change since IPO-79.21%

Recent News & Updates

Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

Oct 04
Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

Recent updates

Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

Oct 04
Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

There's No Escaping Euroapi S.A.'s (EPA:EAPI) Muted Revenues Despite A 32% Share Price Rise

Jul 29
There's No Escaping Euroapi S.A.'s (EPA:EAPI) Muted Revenues Despite A 32% Share Price Rise

Euroapi S.A. (EPA:EAPI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 24
Euroapi S.A. (EPA:EAPI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Euroapi (EPA:EAPI) Seems To Be Using A Lot Of Debt

Apr 10
Euroapi (EPA:EAPI) Seems To Be Using A Lot Of Debt

Little Excitement Around Euroapi S.A.'s (EPA:EAPI) Revenues As Shares Take 31% Pounding

Mar 03
Little Excitement Around Euroapi S.A.'s (EPA:EAPI) Revenues As Shares Take 31% Pounding

Euroapi S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Mar 02
Euroapi S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

A Look At The Fair Value Of Euroapi S.A. (EPA:EAPI)

Dec 21
A Look At The Fair Value Of Euroapi S.A. (EPA:EAPI)

Analysts Are Updating Their Euroapi S.A. (EPA:EAPI) Estimates After Its Half-Yearly Results

Aug 04
Analysts Are Updating Their Euroapi S.A. (EPA:EAPI) Estimates After Its Half-Yearly Results

Is Euroapi S.A. (EPA:EAPI) Trading At A 49% Discount?

Aug 02
Is Euroapi S.A. (EPA:EAPI) Trading At A 49% Discount?

Euroapi S.A.'s (EPA:EAPI) Subdued P/S Might Signal An Opportunity

Jun 16
Euroapi S.A.'s (EPA:EAPI) Subdued P/S Might Signal An Opportunity

An Intrinsic Calculation For Euroapi S.A. (EPA:EAPI) Suggests It's 37% Undervalued

Jan 25
An Intrinsic Calculation For Euroapi S.A. (EPA:EAPI) Suggests It's 37% Undervalued

Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 38% Above Its Share Price

Oct 15
Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 38% Above Its Share Price

Statutory Profit Doesn't Reflect How Good Euroapi's (EPA:EAPI) Earnings Are

Sep 09
Statutory Profit Doesn't Reflect How Good Euroapi's (EPA:EAPI) Earnings Are

Shareholder Returns

EAPIFR PharmaceuticalsFR Market
7D-5.5%2.0%-1.7%
1Y-49.9%1.0%-4.8%

Return vs Industry: EAPI underperformed the French Pharmaceuticals industry which returned 1% over the past year.

Return vs Market: EAPI underperformed the French Market which returned -4.8% over the past year.

Price Volatility

Is EAPI's price volatile compared to industry and market?
EAPI volatility
EAPI Average Weekly Movement10.0%
Pharmaceuticals Industry Average Movement3.5%
Market Average Movement4.5%
10% most volatile stocks in FR Market9.7%
10% least volatile stocks in FR Market2.3%

Stable Share Price: EAPI's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: EAPI's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
20203,329Ludwig De Motwww.euroapi.com/en

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.

Euroapi S.A. Fundamentals Summary

How do Euroapi's earnings and revenue compare to its market cap?
EAPI fundamental statistics
Market cap€267.69m
Earnings (TTM)-€287.30m
Revenue (TTM)€971.30m

0.3x

P/S Ratio

-0.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EAPI income statement (TTM)
Revenue€971.30m
Cost of Revenue€805.80m
Gross Profit€165.50m
Other Expenses€452.80m
Earnings-€287.30m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 11, 2025

Earnings per share (EPS)-3.02
Gross Margin17.04%
Net Profit Margin-29.58%
Debt/Equity Ratio50.9%

How did EAPI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 04:19
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Euroapi S.A. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gary SteventonBNP Paribas Exane
Ben SpruntulisBNP Paribas Exane
Patrick Andrew WoodBofA Global Research